All Brands Owned by Merck & Co.
Merck & Co. owns 9 brands in our database. Browse the complete portfolio of Merck & Co. subsidiaries and brands across various industries.
Company Type
public
Headquarters
Rahway, New Jersey, USA
Brand Portfolio
9 brands
Stock
NYSE: MRK
Filter by Category
Complete Brand Portfolio
Bridion
Owned by Merck & Co.
Prescription medication for reversing neuromuscular blockade during anesthesia, manufactured and marketed by Merck & Co.
Gardasil
Owned by Merck & Co.
Prescription human papillomavirus vaccine for preventing cervical cancer and other HPV-related cancers, manufactured and marketed by Merck & Co.
Isentress
Owned by Merck & Co.
Prescription antiretroviral medication for treating HIV infection by inhibiting integrase enzyme, manufactured and marketed by Merck & Co.
Januvia
Owned by Merck & Co.
Prescription diabetes medication for treating type 2 diabetes by increasing insulin secretion, manufactured and marketed by Merck & Co.
Keytruda
Owned by Merck & Co.
Prescription immunotherapy medication for treating various cancers by activating the immune system, manufactured and marketed by Merck & Co.
Pepcid
Owned by Merck & Co.
Over-the-counter and prescription medication for treating heartburn and acid reflux, manufactured and marketed by Merck & Co.
Propecia
Owned by Merck & Co.
Prescription medication for treating male pattern baldness by inhibiting hair loss, manufactured and marketed by Merck & Co.
Singulair
Owned by Merck & Co.
Prescription medication for treating asthma and allergies by reducing inflammation in the airways, manufactured and marketed by Merck & Co.
Vaseretic
Owned by Merck & Co.
Prescription combination medication for treating high blood pressure, manufactured and marketed by Merck & Co.
About Merck & Co.
What does Merck & Co. own?
Merck & Co. owns a portfolio of pharmaceutical products, vaccines, and animal health products. The company's major brands include Keytruda (oncology immunotherapy), Gardasil (HPV vaccine), Winrevair (pulmonary arterial hypertension), Januvia/Janumet (diabetes), Bridion (anesthesia reversal), and various other prescription medicines. Merck also operates an animal health division under the Merck Animal Health brand, providing veterinary medicines and vaccines.
Is Merck & Co. publicly traded?
Yes, Merck & Co., Inc. trades on the New York Stock Exchange under ticker symbol MRK. The company has no controlling shareholder, with ownership distributed among institutional investors including Vanguard Group, BlackRock, and State Street.
What is Merck's annual revenue?
In FY2024, Merck reported worldwide sales of $64.2 billion, a 7% increase from FY2023. The Pharmaceutical segment generated approximately $57.4 billion and the Animal Health segment approximately $5.8 billion. Keytruda alone accounted for approximately $29.5 billion in FY2024 sales.
Who is Merck's CEO?
Robert M. Davis has served as Chairman and Chief Executive Officer of Merck & Co. since 2021, succeeding Kenneth Frazier. Davis has led the company's strategy of building a post-Keytruda pipeline through acquisitions and internal research investment.
Stock Information
Competitors to Merck & Co.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Novartis | Switzerland | 2009 | Mass market | Global | All-ages | |
| Takeda | Japan | 2018 | Mass market | Europe | All-ages |
Learn More About Competitors
Afinitor
Owned by Novartis
Prescription oncology medication for treating various cancers including renal cell carcinoma and breast cancer, manufactured and marketed by Novartis.
Alofisel
Owned by Unknown Company
Prescription cell therapy for treating complex perianal fistulas in Crohn's disease, manufactured and marketed by Takeda Pharmaceutical Company.
Competitive Analysis
Market Positioning: Merck & Co. competes with 2 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Merck & Co. Brand Portfolio Overview
Merck & Co. maintains a diverse portfolio of 9 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
Brand Portfolio by Industry:
- Healthcare & Pharmaceuticals: 9 brands
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Merck & Co.provides valuable insights into market dynamics, product relationships, and corporate strategy.
Explore More
Jobs at Merck & Co.
Latest News About Merck & Co.
Articles About Merck & Co.
View more articles
Pharmaceutical Brand Ownership: A Complete Guide
Who makes your medications? Discover which corporations own the biggest pharmaceutical brands, from Ozempic to Tylenol, and how pharma M&A affects you.
Monthly M&A Roundup: April 2026 Brand Ownership Changes
Global M&A reached a record $1.3 trillion in Q1 2026, and April is continuing the momentum. McCormick is buying Unilever's food business for $45 billion. Paramount and Warner Bros. Discovery are merging. Here is every major brand ownership shift entering April 2026.
How Sony Built Its Entertainment Empire
Sony started making rice cookers and radio repair equipment in 1946. Today it owns PlayStation, Columbia Pictures, Sony Music, and the world's largest music publishing catalogue. Here is the full story.